{"id":318940,"date":"2025-10-20T16:08:11","date_gmt":"2025-10-20T16:08:11","guid":{"rendered":"https:\/\/www.europesays.com\/us\/318940\/"},"modified":"2025-10-20T16:08:11","modified_gmt":"2025-10-20T16:08:11","slug":"san-diego-workshops-to-focus-on-indolent-systemic-mastocytosis","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/318940\/","title":{"rendered":"San Diego workshops to focus on indolent systemic mastocytosis"},"content":{"rendered":"

\"Poster<\/a>(Courtesy Medscape Live)<\/p>\n

In the complex world of rare diseases, even small advances in understanding can make a profound difference in patients\u2019 lives. Medscape Live<\/a> is bringing back-to-back educational programs to San Diego next month with one shared goal: improving outcomes and connection in indolent systemic mastocytosis, or ISM. <\/p>\n

The paired sessions \u2014 \u201cPatient-Centered Approaches to Indolent Systemic Mastocytosis: Advancing Care and Reducing Diagnostic Delays\u201d for health care professionals, and \u201cBuilding Bridges of Support and Understanding for Patients and Caregivers\u201d for those living with ISM and their loved ones \u2014 will take place Nov. 1 at the Hyatt Regency San Diego. The event represents an innovative, multidimensional approach to medical education that emphasizes empathy, collaboration and actionable learning.<\/p>\n

A new model for medical education<\/p>\n

For decades, continuing medical education programs have focused primarily on scientific discovery and clinical practice. But for conditions like ISM \u2014 a rare, often misunderstood mast cell disorder \u2014 the biggest gaps aren\u2019t in knowledge; they are in awareness, communication and understanding between those who diagnose and those who live with the disease. Medscape Live\u2019s dual-event format directly addresses these issues. By hosting both a professional education program and a patient-caregiver workshop on the same day, in the same city, the initiative invites clinicians and patients into a shared conversation about progress, challenges and the human impact of systemic mastocytosis.<\/p>\n

\u201cPatient-centered\u201d isn\u2019t just a buzzword here; it\u2019s the foundation of both sessions. Clinicians gain insight into how to identify ISM earlier and manage symptoms more effectively, while patients and caregivers gain the knowledge and confidence to advocate for themselves in clinical settings. It\u2019s a full-circle model designed to create ripple effects in both professional practice and daily life.<\/p>\n

Understanding ISM<\/p>\n

Indolent systemic mastocytosis affects mast cells \u2014 immune cells that play a crucial role in allergic responses and inflammation. When these cells grow and accumulate abnormally,<\/p>\n

patients can experience a wide range of symptoms: skin lesions, gastrointestinal discomfort, fatigue, brain fog, anaphylaxis and more. Because these symptoms mimic other conditions, ISM is often misdiagnosed or overlooked, leading to years of uncertainty and frustration for patients.<\/p>\n

For clinicians, the challenge lies in recognizing patterns, ordering the right diagnostic tests (such as tryptase levels and KIT mutation analysis) and understanding the nuances of patient-reported experiences. For patients, the challenge is navigating care, finding knowledgeable providers and managing symptoms that can drastically affect quality of life.<\/p>\n

By addressing both perspectives in one coordinated educational effort, Medscape Live aims to help shorten the diagnostic journey, turning years of unanswered questions into timely, informed care.<\/p>\n

For health care professionals The morning program, \u201cPatient-Centered Approaches to Indolent Systemic Mastocytosis: Advancing Care and Reducing Diagnostic Delays,\u201d will run 8-10 a.m. Nov. 1.<\/p>\n

Designed specifically for physicians, nurse practitioners, physician assistants, pharmacists and other health providers, this interactive symposium will explore:<\/p>\n